Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CASI Pharmaceuticals (CASI)
NASDAQ:CASI
RESEARCH TOOLSreports
Holding CASI?
Track your performance easily
CASI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.05 - $8.48
Previous Close$5.25
Volume9.72K
Average Volume (3M)27.85K
Market Cap
$68.75M
Enterprise Value$58.48M
Total Cash (Recent Filing)$30.77M
Total Debt (Recent Filing)$18.89M
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Apr 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.22
Shares Outstanding15,460,457
10 Day Avg. Volume25,804
30 Day Avg. Volume27,851
Standard Deviation0.28
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)3.37
Price to Sales (P/S)2.44
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.72
Enterprise Value/Gross Profit2.92
Enterprise Value/Ebitda-2.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CASI Pharmaceuticals News
PremiumCompany Announcements
CASI Pharmaceuticals’ Mixed Third-Quarter Performance in 2024
PremiumCompany Announcements
CASI Pharmaceuticals Revamps Management Structure
PremiumCompany Announcements
CASI Pharmaceuticals Shifts Focus, Garners InvestmentOwnership Overview
9.20%
Insiders
0.14% Mutual Funds
9.07% Other Institutional Investors
81.59% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CASI FAQ
What was CASI Pharmaceuticals’s price range in the past 12 months?
CASI Pharmaceuticals lowest stock price was $2.05 and its highest was $8.48 in the past 12 months.
What is CASI Pharmaceuticals’s market cap?
Currently, no data Available
When is CASI Pharmaceuticals’s upcoming earnings report date?
CASI Pharmaceuticals’s upcoming earnings report date is Apr 23, 2025 which is in 151 days.
How were CASI Pharmaceuticals’s earnings last quarter?
CASI Pharmaceuticals released its earnings results on Nov 14, 2024. The company reported -$0.549 earnings per share for the quarter, beating the consensus estimate of -$0.62 by $0.071.
Is CASI Pharmaceuticals overvalued?
According to Wall Street analysts CASI Pharmaceuticals’s price is currently Overvalued.
Does CASI Pharmaceuticals pay dividends?
CASI Pharmaceuticals does not currently pay dividends.
What is CASI Pharmaceuticals’s EPS estimate?
CASI Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CASI Pharmaceuticals have?
CASI Pharmaceuticals has 13,401,375 shares outstanding.
What happened to CASI Pharmaceuticals’s price movement after its last earnings report?
CASI Pharmaceuticals reported an EPS of -$0.549 in its last earnings report, beating expectations of -$0.62. Following the earnings report the stock price went up 5.946%.
Which hedge fund is a major shareholder of CASI Pharmaceuticals?
Among the largest hedge funds holding CASI Pharmaceuticals’s share is Woodline Partners LP. It holds CASI Pharmaceuticals’s shares valued at 188K.
---
CASI Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.89%
12-Months-Change
Fundamentals
Return on Equity
-136.05%
Trailing 12-Months
Asset Growth
-11.64%
Trailing 12-Months
Company Description
CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
---
CASI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering CASI
1 Year
1 Year Success Rate
4/16 ratings generated profit
1 Year Average Return
-13.97%
reiterated a buy rating 6 months ago
Copying Sean Lee CFA's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -13.97% per trade.
---